Introduction: The development of a PLGA Long-Acting Injectable Formulation for a GLP-1 receptor agonist can provide an important strategy for … Continue reading Case Study: PLGA Long-Acting Injectable Formulation Development for a GLP-1 Receptor Agonist in Type 2 Diabetes